Claim
descriptive

Even though Hashimoto’s and Graves’ disease involve different antibodies and opposite hormone effects, the types and arrangements of immune cells in the thyroid are surprisingly similar between the two conditions.

Claim Context

Scientific statement

The immune cell composition in thyroid tissue from patients with Hashimoto’s thyroiditis and Graves’ disease shows greater similarity to each other than expected, despite differences in autoantibody targets and clinical outcomes.

Original statement
We found that, despite markedly different clinical presentations and distinct antigenic triggers, HT and GD exhibit convergent cellular dynamics resulting in a shared continuum of immune infiltration.

Evidence from Studies

No evidence studies found yet.

What Would Prove This

Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.

1
Systematic Reviews & Meta-Analyses

Whether immune cell profiles in thyroid tissue are consistently more similar between Hashimoto’s and Graves’ than between either and non-autoimmune controls across multiple studies.

A systematic review and meta-analysis of all published single-cell datasets from human thyroid tissue in HT, GD, and non-autoimmune controls, using standardized clustering and dimensionality reduction to quantify inter-group similarity scores.

2
Randomized Controlled Trials

Whether altering autoantibody specificity in a model system changes the overall immune cell composition in thyroid tissue.

A double-blind, placebo-controlled trial in 60 patients with Graves’ disease, randomized to receive a monoclonal antibody targeting TSH receptor vs. a control antibody, with thyroid biopsy before and after 6 months to assess changes in immune cell composition.

3
Cohort Studies

Whether patients with mixed autoantibody profiles (e.g., TPO+ and TSHR+) have immune profiles intermediate between classic HT and GD.

A prospective cohort study of 400 patients with autoimmune thyroid disease, stratified by autoantibody profile (TPO-only, TSHR-only, both, neither), with baseline and 1-year thyroid immune profiling via single-cell sequencing to assess clustering patterns.

4
Case-Control Studies

Whether patients with Hashimoto’s and Graves’ disease have more similar immune profiles than patients with other autoimmune thyroid conditions.

A case-control study comparing immune profiles in 100 HT patients, 100 GD patients, and 50 patients with other thyroid autoimmunity (e.g., Riedel’s thyroiditis), matched for age, sex, and disease duration, using standardized single-cell analysis.

5
Cross-Sectional Studies
In Evidence

Whether immune cell proportions in thyroid tissue are more similar between HT and GD than between either and non-autoimmune controls.

A cross-sectional analysis of 200 thyroidectomy specimens: 100 HT, 100 GD, with blinded quantification of 20+ immune cell types via multiplex immunofluorescence and clustering analysis to compare intra- and inter-group similarity.

Sign up to see full verdict